AI Offers New Pathways to Strengthen Site Leadership
Artificial intelligence can help identify key opinion leaders in emerging markets, improving site influence, patient engagement, and trial success.
In a video interview, Gen Li, PhD, MBA, president of Phesi, discussed results from the company's analysis on global inequity in breast cancer development.
- Geographic concentration of breast cancer trial leaders is in the US and China.
- Operational barriers in lower-income countries are due to traditional business models.
- AI and machine learning can implement a patient-centric approach.
Identifying local leaders and redistributing trial workloads can improve recruitment by using AI to identify and activate new sites.
Author's summary: AI helps identify key opinion leaders in emerging markets.